In conclusion, we constructed a replication-deficient adenoviral vector containing a cDNA encoding a secreted, EpCAM-targeted form of human liver CE2 that was capable of converting the prodrug CPT-11 into its activated form, leading to enhanced toxicity of CPT-11 to colon cancer spheroids. Here, EPCAM is linked to malignant colon neoplasm.